In PDAC, early sequencing studies identified genetic alterations in the integrin signalling pathway (ITGA4, ITGA9, ITGA11, LAMA1, LAMA4, LAMA5, FN1 and ILK) in 67% of tumours 18. This evidence concerns the gene FN1 and neoplasm.